Synlett 2016; 27(02): 241-244
DOI: 10.1055/s-0035-1560505
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Tetrazole-Containing C-Phosphonoacetamidines

Nataly I. Svintsitskaya*
a   Saint-Petersburg State University, Universitetskii pr. 26, Saint Petersburg 198504, Russian Federation   Email: nsvincickaya@mail.ru
,
Albina V. Dogadina
b   Saint-Petersburg State Institute of Technology (Technical University), Moskovskii pr. 26, Saint Petersburg 190013, Russian Federation
,
Rostislav E. Trifonov
a   Saint-Petersburg State University, Universitetskii pr. 26, Saint Petersburg 198504, Russian Federation   Email: nsvincickaya@mail.ru
› Author Affiliations
Further Information

Publication History

Received: 21 August 2015

Accepted: 15 September 2015

Publication Date:
20 October 2015 (online)


Abstract

Addition of 5-substituted tetrazoles to dialkyl 2-(N-tert-butyl- or N-adamantyl)iminovinylphosphonates proceeds regioselectively to yield novel tetrazole-containing phosphonoacetamidines – 2-[(N-tert-butyl- or N-adamantyl)imino-2-(tetrazolyl)ethyl]phosphonic acid dialkyl esters – with good yields. The reactions occur via nucleophilic attack of the tetrazole N-1 atom at the C=C bond.

Supporting Information

 
  • References and Notes

  • 1 Gautier J.-A, Miocque M, Combet Farnoux C In The Chemistry of Amidines and Imidates . Vol. 1. Patai S. Wiley; London: 1975: 283-348
  • 2 Boyd GV In The Chemistry of Amidines and Imidates . Vol. 2. Patai S, Rappoport Z. Wiley; London: 1991: 367-424
  • 3 Ishikawa T, Kumamoto T In Superbases for Organic Synthesis . Ishikawa T. John Wiley and Sons; Chichester: 2009: 49-92
  • 4 Aly AA, Nour-El-Din AM. ARKIVOC 2008; (i): 153
  • 5 Edelmann FT. Chem. Soc. Rev. 2009; 38: 2253
  • 6 Singh B. Int. J. ChemTech Res. 2009; 1: 250
  • 7 Edelmann FT. Adv. Organomet. Chem. 2008; 57: 183
  • 8 Nagasawa K In Superbases for Organic Synthesis . Ishikawa T. John Wiley and Sons; Chichester: 2009: 211-250
  • 9 Guile SD, Alcaraz L, Birkinshaw TN, Bowers KC, Ebden MR, Furber M, Stocks MJ. J. Med. Chem. 2009; 52: 3123
  • 10 Greenhill JV, Lue P. Prog. Med. Chem. 1993; 30: 203
  • 11 Caron S, Wei L, Douville J, Ghosh A. J. Org. Chem. 2010; 75: 945
  • 12 Toy AD. F, Walsh EN. Phosphorus Chemistry in Everyday Living . American Chemical Society; Washington: 1987
  • 13 Yudelevich VI, Ionin BI. Organophosphorus Drugs . Thesa; St. Petersburg: 1995
  • 14 Herr RJ. Bioorg. Med. Chem. 2002; 10: 3379
  • 15 Myznikov LV, Hrabalek A, Koldobskii GI. Chem. Heterocycl. Compd. 2007; 43: 1
  • 16 Ostrovskii VA, Trifonov RE, Popova EA. Russ. Chem. Bull. Int. Ed. 2012; 61: 768
  • 17 Malik MA, Wani MY, Al-Thabaiti SA, Shiekh RA. J. Inclusion Phenom. Macrocyclic Chem. 2014; 78: 13
  • 18 Aromí G, Barriosa LA, Roubeaub O, Gamez P. Coord. Chem. Rev. 2011; 255: 485
  • 19 Durant GJ, Young RC, Tashma Z. EP 7326 198000206, 1980 ; Chem. Abstr. 1980, 93, 168317.
  • 20 Palacios F, Ochoa de Retana AM, Pagalday J. Eur. J. Org. Chem. 2003; 913
  • 21 Shishkin VE, Mednikov EV, Shevchenko MA, Anishchenko OV, Popov YV, Gurba EV, Bang CN. Russ. J. Gen. Chem. 2010; 80: 60
  • 22 Panarina AE, Aleksandrova AV, Dogadina AV, Ionin BI. Russ. J. Gen. Chem. 2005; 75: 3
  • 23 Kawai N, Kato N, Hamada Y, Shiori T. Chem. Pharm. Bull. 1983; 31: 3139
  • 24 Khayat MA. R, Al-Isa IS. J. Prakt. Chem. 1989; 331: 149
  • 25 Suyama T, Fujiyama Y. Nippon Kagaku Kaishi 1992; 11: 1344 ; Chem. Abstr. 1993, 118, 124637
  • 26 Rossi E, Calabrese D, Parma F. Tetrahedron 1991; 47: 5819
  • 27 Aleksandrova AV, Dogadina AV, Ionin BI. Russ. J. Gen. Chem. 2005; 75: 1664
  • 28 Svintsitskaya NI, Dogadina AV, Ionin BI. Russ. J. Gen. Chem. 2008; 78: 2031
  • 29 Svintsitskaya NI, Dogadina AV, Ionin BI. Russ. J. Gen. Chem. 2011; 81: 628
  • 30 Leonov AA, Dogadina AV, Ionin BI, Petrov AA. J. Gen. Chem. USSR (Engl. Transl.) 1983; 53: 233
  • 31 Garibina VA, Dogadina AV, Ionin BI, Petrov AA. J. Gen. Chem. USSR (Engl. Transl.) 1979; 49: 2385
  • 32 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA. Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian 09, Revision D.01. Gaussian; Wallingford: 2013
  • 33 Motoyoshiya J, Teranishi A, Mikoshiba R, Yamamoto I, Gotho H. J. Org. Chem. 1980; 45: 5385
  • 34 Lu P, Wang Y. Chem. Soc. Rev. 2012; 41: 5687
  • 35 Kolodyazhnyi OI, Yakovlev VN. J. Gen. Chem. USSR (Engl. Transl.) 1980; 50: 55
  • 36 Svintsitskaya NI, Dogadina AV, Starova GL, Trifonov RE. Tetrahedron Lett. 2014; 55: 5381
  • 37 Ostrovskii VA, Koren AO. Heterocycles 2000; 53: 1421
  • 38 Typical Experimental Procedure for the Synthesis of Compounds 3a–l A mixture of dimethyl 2-N-tert-butyliminoethenephosphonate (1a, 25 mmol) or diethyl 2-(N-adamant-1-yl)iminoethenephosphonate (1b) and the corresponding NH-tetrazole 2af (25 mmol) in anhydrous CCl4 (10 mL) was stirred vigorously under reflux for 15 h. After the reaction was completed, the solvent was removed. The residue was chromatographed on silica gel eluting with a mixture of EtOAc–hexane (1:3). (2-tert-Butylimino-2-tetrazol-1-ylethyl)phosphonic Acid Dimethyl Ester (3a) Yield 77%, pale yellow oil. 1H NMR (400.13 MHz, CDCl3): δ = 1.60 (s, 9 H, CH3), 2.64 (d, 2 J PH = 24.1 Hz, 2 H, PCH2), 3.67 (d, 3 J HP = 10.9 Hz, 6 H, OCH3), 8.17 (s, 1 H, CH, tetrazole). 13C NMR (100.61 MHz, CDCl3): δ = 28.36 (s, CH3, t-Bu), 35.04 (d, 1 J PC = 137.3 Hz, PCH2), 51.59 (s, C, t-Bu), 53.11 (d, 2 J CP = 6.7 Hz, OCH3), 140.16 (s, C, ring), 163.16 (d, 3 J CP = 4.0 Hz, C=N). 31P NMR (161.98 MHz, CDCl3): δ = 25.84. ESI-HRMS: m/z calcd for C9H19N5O3P: 276.1220; found: 276.1231 [M + H]+. [2-(Adamantan-1-ylimino)-2-(5-methyltetrazol-1-yl)ethyl]-phosphonic Acid Diethyl Ester (3h) Yield 82%, pale yellow oil. 1H NMR (400.13 MHz, CDCl3): δ =.17 (t, 3 J HH = 7.4 Hz, 6 H, CH3), 1.63 (br, 6 H, CH2, adamant.), 1.78 (br, 6 H, CH2, adamant.), 1.95 (m, 3 H, CH, adamant.), 2.28 (s, CH3, tetrazole), 2.73 (d, 2 J PH = 20.6 Hz, 2 H, PCH2), 4.12 (q, 3 J HP = 7.3 Hz, 4 H, OCH2). 13C NMR (100.61 MHz, CDCl3): δ = 8.54 (s, CH3, tetrazole), 16.06 (s, CH3), 29.12 (CH, adamant.), 35.95 (d, 1 J PC = 131.8 Hz, PCH2), 36.04 (s, γ-CH2, adamant.), 40.94 (α-CH2, adamant.), 52.26 (C–N, adamant.), 62.66 (d, CH2OP, 2 J CP = 6.0 Hz), 152.41 (s, C, tetrazole), 163.32 (d, C=N, 2 J CP = 5.0 Hz). 31P NMR (161.98 MHz, CDCl3): δ = 23.47. ESI-HRMS: m/z calcd for C18H30N5O3PNa: 418.4254; found: 418.4196 [M + Na]+.
  • 39 Ostrovskii VA, Koldobskii GI, Trifonov RE. Comprehensive Heterocyclic Chemistry III . Katritzky AR, Ramsden CA, Scriven EF. V, Taylor RJ. K. Elsevier; Oxford: 2008